RedHill Biopharma Statistics
Total Valuation
RDHL has a market cap or net worth of $4.00 million. The enterprise value is $1.34 million.
Important Dates
The last earnings date was Friday, September 5, 2025, before market open.
| Earnings Date | Sep 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RDHL has 3.33 million shares outstanding. The number of shares has increased by 97.35% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.33M |
| Shares Change (YoY) | +97.35% |
| Shares Change (QoQ) | +39.93% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 2.73% |
| Float | 3.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.56
| Current Ratio | 0.56 |
| Quick Ratio | 0.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -25.32% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 209.20% |
| Revenue Per Employee | $272,857 |
| Profits Per Employee | -$266,086 |
| Employee Count | 35 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.35% in the last 52 weeks. The beta is 4.82, so RDHL's price volatility has been higher than the market average.
| Beta (5Y) | 4.82 |
| 52-Week Price Change | -84.35% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 48.80 |
| Average Volume (20 Days) | 100,723 |
Short Selling Information
| Short Interest | 194,835 |
| Short Previous Month | 179,078 |
| Short % of Shares Out | 6.33% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, RDHL had revenue of $9.55 million and -$9.31 million in losses. Loss per share was -$6.02.
| Revenue | 9.55M |
| Gross Profit | 6.16M |
| Operating Income | -8.18M |
| Pretax Income | -9.31M |
| Net Income | -9.31M |
| EBITDA | -8.34M |
| EBIT | -8.18M |
| Loss Per Share | -$6.02 |
Full Income StatementBalance Sheet
The company has $2.87 million in cash and $214,000 in debt, giving a net cash position of $2.65 million or $0.80 per share.
| Cash & Cash Equivalents | 2.87M |
| Total Debt | 214,000 |
| Net Cash | 2.65M |
| Net Cash Per Share | $0.80 |
| Equity (Book Value) | -4.41M |
| Book Value Per Share | -2.45 |
| Working Capital | -9.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.20 million and capital expenditures -$12,000, giving a free cash flow of -$8.21 million.
| Operating Cash Flow | -8.20M |
| Capital Expenditures | -12,000 |
| Free Cash Flow | -8.21M |
| FCF Per Share | -$2.47 |
Full Cash Flow StatementMargins
Gross margin is 64.45%, with operating and profit margins of -85.70% and -97.52%.
| Gross Margin | 64.45% |
| Operating Margin | -85.70% |
| Pretax Margin | -97.52% |
| Profit Margin | -97.52% |
| EBITDA Margin | -87.29% |
| EBIT Margin | -85.70% |
| FCF Margin | n/a |